NuVasive contends that Globus Medical’s LLIF lateral fusion offering — including instrumentation, implants and techniques under the trademarks of TransContinental, MARS 3V and LLIF — infringe on NuVasive’s XLIF intellectual property. The XLIF is a procedure for minimally invasive lumbar fusions.
Globus Medical has not responded to the NuVasive lawsuit.
Read the NuVasive release on patent infringement.
Read other coverage on NuVasive:
– Two Insurers Reverse Policies to Cover Procedures
– NuVasive Reports 2Q Revenue Up 35.2%
– Vail-Summit Spine Surgoen First to Use MAS-TLIF for Minimally Invasive Spine Fusion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
